Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Ketamine and Morphine for Postoperative Pain in Abdominal Cancer Surgery
NCT02726828Phase 3
Key facts
- Status
- Completed
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Sponsor
- Assiut University
- Modality
- Small Molecules
- Drugs
- ketamine
- Conditions
- postoperative pain
01
Overview
Phase 3, randomised, double-blind trial of ketamine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoints: Visual Analogue Scale, Time to first analgesic request and 1 more. Started Oct 2015; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Morphine Group
Morphine 0.3mg + Bupivacaine
Ketamine Group
Ketamine 0.1mg/kg + Bupivacaine
Combination Group
Morphine 0.3mg + Ketamine 0.1mg/kg + Bupivacaine
03
Who it enrols
Adult patients aged 30-50 undergoing major abdominal cancer surgery, excluding those with significant organ disease, coagulation disorders, or BMI > 30.
04
Endpoints
Primary
Visual Analogue Scale
Time to first analgesic request
Total analgesic consumption
Secondary
Side effects
Beyond the preview
Go deeper on NCT02726828.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726828.